Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amarin Corporation Plc (AMRN)
NASDAQ:AMRN
Holding AMRN?
Track your performance easily
AMRN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.46 - $1.37
Previous Close$0.52
Volume1.37M
Average Volume (3M)918.77K
Market Cap
$215.87M
Enterprise Value-$82.63M
Total Cash (Recent Filing)$306.60M
Total Debt (Recent Filing)$8.10M
Price to Earnings (P/E)―
Beta1.81
Next Earnings
Feb 26, 2025EPS Estimate
-$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding411,338,131
10 Day Avg. Volume1,566,273
30 Day Avg. Volume918,770
Standard Deviation0.24
R-Squared0.18
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.38
Price to Sales (P/S)0.84
Price to Cash Flow (P/CF)-21.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.31
Enterprise Value/Gross Profit-0.50
Enterprise Value/Ebitda2.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Amarin News
PremiumCompany Announcements
Amarin Corporation: Q3 Highlights and Future Outlook
Ownership Overview
0.46% Insiders
0.10% Mutual Funds
12.66% Other Institutional Investors
86.55% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMRN FAQ
What was Amarin Corporation Plc’s price range in the past 12 months?
Amarin Corporation Plc lowest stock price was $0.46 and its highest was $1.37 in the past 12 months.
What is Amarin Corporation Plc’s market cap?
Currently, no data Available
When is Amarin Corporation Plc’s upcoming earnings report date?
Amarin Corporation Plc’s upcoming earnings report date is Feb 26, 2025 which is in 95 days.
How were Amarin Corporation Plc’s earnings last quarter?
Amarin Corporation Plc released its earnings results on Oct 30, 2024. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of -$0.056 by -$0.004.
Is Amarin Corporation Plc overvalued?
According to Wall Street analysts Amarin Corporation Plc’s price is currently Overvalued.
Does Amarin Corporation Plc pay dividends?
Amarin Corporation Plc does not currently pay dividends.
What is Amarin Corporation Plc’s EPS estimate?
Amarin Corporation Plc’s EPS estimate is -$0.05.
How many shares outstanding does Amarin Corporation Plc have?
Amarin Corporation Plc has 411,338,130 shares outstanding.
What happened to Amarin Corporation Plc’s price movement after its last earnings report?
Amarin Corporation Plc reported an EPS of -$0.06 in its last earnings report, missing expectations of -$0.056. Following the earnings report the stock price went down -3.333%.
Which hedge fund is a major shareholder of Amarin Corporation Plc?
Among the largest hedge funds holding Amarin Corporation Plc’s share is SCP Investment, LP. It holds Amarin Corporation Plc’s shares valued at 2M.
---
Amarin Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AMRN Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 52.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 4.9%
Last 30 Days ▲ 4.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.85%
12-Months-Change
Fundamentals
Return on Equity
-7.31%
Trailing 12-Months
Asset Growth
-10.54%
Trailing 12-Months
Company Description
Amarin Corporation Plc
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
---
AMRN Earnings Call
Q3 2024
0:00 / 0:00
---
AMRN Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering AMRN
1 Year
1 Year Success Rate
11/12 ratings generated profit
1 Year Average Return
+32.22%
reiterated a sell rating 4 months ago
Copying Paul Choi's trades and holding each position for 1 Year would result in 91.67% of your transactions generating a profit, with an average return of +32.22% per trade.
---